News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,273 Results
Type
Article (41641)
Company Profile (257)
Press Release (663375)
Section
Business (206451)
Career Advice (2137)
Deals (36150)
Drug Delivery (101)
Drug Development (81796)
Employer Resources (170)
FDA (16293)
Job Trends (15102)
News (349679)
Policy (33490)
Tag
Academia (2653)
Alliances (49851)
Alzheimer's disease (1336)
Approvals (16277)
Artificial intelligence (212)
Bankruptcy (360)
Best Places to Work (11839)
Biotechnology (181)
Breast cancer (232)
Cancer (1792)
Cardiovascular disease (133)
Career advice (1771)
CAR-T (131)
Cell therapy (373)
Clinical research (65887)
Collaboration (697)
Compensation (383)
COVID-19 (2665)
C-suite (179)
Data (1708)
Diabetes (227)
Diagnostics (6396)
Earnings (86253)
Employer resources (146)
Events (112964)
Executive appointments (592)
FDA (17255)
Funding (628)
Gene therapy (257)
GLP-1 (681)
Government (4649)
Healthcare (19225)
Infectious disease (2790)
Interviews (325)
IPO (17031)
Job creations (3704)
Job search strategy (1517)
Layoffs (450)
Legal (8133)
Lung cancer (259)
Manufacturing (246)
Medical device (13434)
Medtech (13439)
Mergers & acquisitions (19524)
Metabolic disorders (586)
Neuroscience (1760)
NextGen: Class of 2025 (6629)
Non-profit (4669)
Northern California (2209)
Obesity (323)
Opinion (211)
Patents (174)
People (57962)
Phase I (20498)
Phase II (29048)
Phase III (21593)
Pipeline (798)
Postmarket research (2605)
Preclinical (8725)
Radiopharmaceuticals (245)
Rare diseases (335)
Real estate (5974)
Regulatory (22513)
Research institute (2386)
Resumes & cover letters (380)
Southern California (1885)
Startups (3634)
United States (19361)
Vaccines (654)
Weight loss (225)
Date
Today (160)
Last 7 days (787)
Last 30 days (2838)
Last 365 days (34602)
2025 (5508)
2024 (35508)
2023 (40452)
2022 (51646)
2021 (56285)
2020 (54954)
2019 (47576)
2018 (35878)
2017 (32643)
2016 (32201)
2015 (38219)
2014 (31934)
2013 (26952)
2012 (29118)
2011 (29823)
2010 (27803)
Location
Africa (759)
Arizona (213)
Asia (38393)
Australia (6306)
California (5016)
Canada (1758)
China (416)
Colorado (228)
Connecticut (238)
Europe (83439)
Florida (734)
Georgia (175)
Illinois (473)
Indiana (276)
Japan (127)
Maryland (784)
Massachusetts (3810)
Michigan (201)
Minnesota (347)
New Jersey (1425)
New York (1429)
North Carolina (866)
Northern California (2209)
Ohio (176)
Pennsylvania (1137)
South America (1129)
Southern California (1885)
Texas (733)
Utah (155)
Washington State (476)
705,273 Results for "biocentury publications inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 20, 2025
·
5 min read
Press Releases
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
February 5, 2025
·
3 min read
Press Releases
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
February 4, 2025
·
3 min read
Press Releases
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 6, 2025
·
5 min read
Press Releases
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
January 28, 2025
·
6 min read
Press Releases
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
January 29, 2025
·
3 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock
December 11, 2024
·
6 min read
Press Releases
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 30, 2025
·
3 min read
Press Releases
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
·
5 min read
1 of 70,528
Next
